Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study
Published: 11 September 2023| Version 1 | DOI: 10.17632/ss5xy6j3jy.1
Contributors:
Sokounthie Ou, Emmanuelle Tancrède-Bohin, Marina Alexandre, Saskia Ingen-Housz-Oro, Marion Castel, Sébastien Debarbieux, Sophie Duvert-Lehembre, Maria Polina Konstantinou, Claire Abasq, Clémence Berthin, Caroline Couzan, Clémence Lepelletier, Lamia Jelti, Julie Bouteiller, Andreea Calugareanu, Marie Véron, Frédéric Caux, pascal Joly, Bérenger Thomas, Manuelle ViguierDescription
Supplemental Material concerning our study "Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study" Materials and Methods, supplemental figures and supplemental tables
Files
Institutions
Universite de Reims Champagne-Ardenne
Categories
Dermatology, Autoimmune Skin Disease, Bullous Disease